Maze Therapeutics, Inc. Common Stock (MAZE) — Cash Flow Reinvestment Rate
Maze Therapeutics, Inc. Common Stock (MAZE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $320.00K (capex $160.00K plus investments $-160.00K) from operating cash flow of $145.05 Million. Explore Maze Therapeutics, Inc. Common Stock capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Also explore total assets of Maze Therapeutics, Inc. Common Stock for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year capital reinvestment analysis for Maze Therapeutics, Inc. Common Stock. For live market cap and broader valuation context, see MAZE company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $2.29 Million | $75.95 Million | $1.15 Million | — |